Breast cancer family history assessment and counseling

3^rd World Conference on Breast and Cervical Cancer

September 24-25, 2018 Abu Dhabi, UAE

Mohamad Al-Gailani

Al Hammadi Hospital Al-Suwaidi, Saudi Arabia

Scientific Tracks Abstracts: J Integr Oncol

Abstract :

Breast cancer is the commonest female malignancy accounting for about 22% of all new female cancers. It is expected to affect 1:8 (12%) of women during their life time. The incidence in the Gulf and Arab world is approaching that in the West. Many women are anxious about their family history of breast cancer and what-if anything-they can do about it. In this presentation we will discuss breast cancer susceptibility and how to reduce the risk in general, the relevance of the individualâ??s family history, the objective assessment and risk stratification of family history and whether the Oral Contraceptive Pill (OCP) and Hormone Replacement Therapy (HRT) could increase the risk? Finally, what are the modern options available for a woman with a significant family history of breast cancer? It includes review of the latest NICE UK guidelines on breast screening, chemoprevention and risk reducing bilateral skin sparing mastectomy with immediate reconstruction.

Biography :

Mohamad Al-Gailani is a Consultant Breast and General and Surgeon and In-Charge of Department of Surgery at Al Hammadi Hospital Al-Suwaidi, Nuzha Riyadh, KSA. He has also worked with NHS Foundation Trust, Rotherham, United Kingdom. He was the Member of British Association of Surgical Oncology and also the Member of Association of Breast Surgery.

E-mail: muhammad.gailani@alhammadi.com